Citadel Advisors
CLLS

Citadel Advisors’s Cellectis CLLS Stock Holding History

Citadel Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Sell
44,315
-51,112
-54% -$196K ﹤0.01% 11740
2025
Q4 		$462K Sell
95,427
-126,532
-57% -$529K ﹤0.01% 9218
2025
Q3 		$633K Buy
+221,959
New +$575K ﹤0.01% 8562
2025
Q1 		– Sell
-34,786
Closed -$62.6K – 14583
2024
Q4 		$62.6K Buy
34,786
+7,162
+26% +$13.4K ﹤0.01% 12133
2024
Q3 		$59.1K Buy
27,624
+925
+3% +$2.01K ﹤0.01% 11726
2024
Q2 		$49.9K Buy
+26,699
New +$70K ﹤0.01% 11761
2024
Q1 		– Sell
-17,784
Closed -$54.8K – 14638
2023
Q4 		$54.8K Sell
17,784
-16,516
-48% -$39.2K ﹤0.01% 11682
2023
Q3 		$54.2K Buy
34,300
+4,317
+14% +$8.43K ﹤0.01% 11670
2023
Q2 		$59.1K Buy
+29,983
New +$57.5K ﹤0.01% 11608
2023
Q1 		– Sell
-58,207
Closed -$122K – 14799
2022
Q4 		$122K Buy
58,207
+45,849
+371% +$104K ﹤0.01% 10931
2022
Q3 		$28K Sell
12,358
-11,231
-48% -$34K ﹤0.01% 11936
2022
Q2 		$67K Buy
+23,589
New +$83.1K ﹤0.01% 11733
2022
Q1 		– Sell
-42,418
Closed -$234K – 13681
2021
Q4 		$344K Buy
42,418
+1,267
+3% +$12.5K ﹤0.01% 10608
2021
Q3 		$519K Buy
41,151
+27,862
+210% +$386K ﹤0.01% 9769
2021
Q2 		$206K Sell
13,289
-25,928
-66% -$436K ﹤0.01% 12093
2021
Q1 		$793K Buy
39,217
+24,325
+163% +$601K ﹤0.01% 8664
2020
Q4 		$403K Sell
14,892
-22,889
-61% -$513K ﹤0.01% 8554
2020
Q3 		$699K Sell
37,781
-133,498
-78% -$2.37M ﹤0.01% 6690
2020
Q2 		$3.05M Sell
171,279
-84,749
-33% -$1.29M ﹤0.01% 3843
2020
Q1 		$2.35M Sell
256,028
-242,403
-49% -$3.62M ﹤0.01% 3884
2019
Q4 		$8.53M Sell
498,431
-10,055
-2% -$134K ﹤0.01% 2384
2019
Q3 		$5.29M Buy
508,486
+452,729
+812% +$6.09M ﹤0.01% 3035
2019
Q2 		$870K Sell
55,757
-6,609
-11% -$118K ﹤0.01% 5920
2019
Q1 		$1.14M Buy
62,366
+4,251
+7% +$75.3K ﹤0.01% 5357
2018
Q4 		$968K Sell
58,115
-95,657
-62% -$2.22M ﹤0.01% 5358
2018
Q3 		$4.34M Sell
153,772
-23,722
-13% -$682K ﹤0.01% 3177
2018
Q2 		$5.02M Buy
177,494
+147,961
+501% +$4.41M ﹤0.01% 2772
2018
Q1 		$931K Sell
29,533
-22,667
-43% -$716K ﹤0.01% 4928
2017
Q4 		$1.52M Buy
52,200
+39,174
+301% +$1.07M ﹤0.01% 4012
2017
Q3 		$371K Hold
13,026
– – ﹤0.01% 5734
2017
Q2 		$336K Hold
13,026
– – ﹤0.01% 5716
2017
Q1 		$313K Hold
13,026
– – ﹤0.01% 5825
2016
Q4 		$221K Sell
13,026
-17,112
-57% -$316K ﹤0.01% 6156
2016
Q3 		$726K Sell
30,138
-3
-0% -$78 ﹤0.01% 4282
2016
Q2 		$801K Sell
30,141
-21,304
-41% -$625K ﹤0.01% 3856
2016
Q1 		$1.42M Sell
51,445
-12,055
-19% -$290K ﹤0.01% 3053
2015
Q4 		$1.97M Sell
63,500
-28,316
-31% -$859K ﹤0.01% 2758
2015
Q3 		$2.42M Buy
91,816
+1,234
+1% +$41.3K ﹤0.01% 2710
2015
Q2 		$3.27M Sell
90,582
-4,574
-5% -$161K ﹤0.01% 2497
2015
Q1 		$3.29M Buy
+95,156
New +$3.45M ﹤0.01% 2487

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citadel Advisors's CLLS Position: Q1 2026 in Review

Citadel Advisors reduced its Cellectis (CLLS) stake by 54% in Q1 2026, selling an estimated $196K and leaving 44,315 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #11740.

Citadel Advisors first reported a position in CLLS in Q1 2015 and has held it in 40 quarters since. The position peaked at $8.53M in Q4 2019. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Citadel Advisors held 44,315 shares of Cellectis worth $140K as of Q1 2026.
  • Citadel Advisors sold 51,112 Cellectis shares in Q1 2026, an estimated $196K.
  • Cellectis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11740 holding.
  • Citadel Advisors first reported a position in Cellectis in Q1 2015 and has held it in 40 quarters since.
  • Citadel Advisors's Cellectis position peaked at $8.53M in Q4 2019.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.